Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hodgkin's Disease 2015 NCI 5R01CA085180-14 Epstein-Barr Virus LMP1-Mediated Oncogenecity KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $701,405
Hodgkin's Disease 2015 NCI 5R01CA170023-03 Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $392,517
Hodgkin's Disease 2015 NCI 5R01CA157660-04 The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis KLEIN, ULF COLUMBIA UNIVERSITY HEALTH SCIENCES NY $331,240
Hodgkin's Disease 2015 NCI 5R01CA174794-03 Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic Radiation KRULL, KEVIN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $642,665
Hodgkin's Disease 2015 NCI 5R01CA160300-05 Cellular Response to Short Telomeres in B-Cell Lymphoma GREIDER, CAROL JOHNS HOPKINS UNIVERSITY MD $519,945
Hodgkin's Disease 2015 NCI 5R01CA047006-28 Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation KIEFF, ELLIOTT BRIGHAM AND WOMEN'S HOSPITAL MA $565,231
Hodgkin's Disease 2015 NIAID 1R01AI114557-01A1 Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $434,048
Hodgkin's Disease 2015 NIAID 5R44AI096588-04 Development of a Small Molecule Inhibitor for EBV Latent Infection VAN DEN HEUVEL, PIETER VIRONIKA, LLC PA $750,000
Hodgkin's Disease 2015 NCI 5R01CA140337-05 Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation LUFTIG, MICAH DUKE UNIVERSITY NC $325,775
Hodgkin's Disease 2015 NCI 5K05CA160724-05 Survivorship: Mentoring and Bridging Primary Care and Oncology OEFFINGER, KEVIN SLOAN-KETTERING INST CAN RESEARCH NY $164,278
Hodgkin's Disease 2015 NCI 5K24CA184039-02 Molecularly Targeted Therapy for Lymphoma GOPAL, AJAY UNIVERSITY OF WASHINGTON WA $174,048
Hodgkin's Disease 2015 NCI 5R01CA161026-05 Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies SHIPP, MARGARET DANA-FARBER CANCER INST MA $425,165
Hodgkin's Disease 2015 NCI 5R21CA188824-02 Plasma and serum biomarkers for Hodgkin lymphoma AMBINDER, RICHARD JOHNS HOPKINS UNIVERSITY MD $178,438
Hodgkin's Disease 2015 NCI 5P50CA126752-09 0001 T CELL THERAPY TARGETING MULTIPLE TUMOR ANTIGENS IN HODGKIN LYMPHOMA LEEN, ANN BAYLOR COLLEGE OF MEDICINE TX $235,961
Hodgkin's Disease 2015 NCI 1R21CA185875-01A1 Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM SMITH, EILEEN CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CA $207,513
Hodgkin's Disease 2015 NIAID 1R41AI115834-01A1 sxRNA-based Antiviral Approach targeting Epstein-Barr virus BHADURI-MCINTOSH, SUMITA HOCUSLOCUS, LLC NY $225,000
Hodgkin's Disease 2015 NCI 261200800001E-77-0-36 Repository Services for epidemiology studies HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. MD $2,282,355
Hodgkin's Disease 2015 NCI 3R01CA140337-05S1 Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation LUFTIG, MICAH DUKE UNIVERSITY NC $66,880
Hodgkin's Disease 2015 NCI 1ZIABC011070-08 Hematopathology Diagnosis JAFFE, ELAINE NIH $954,859
Hodgkin's Disease 2015 NCI 1ZIACP005803-21 Genetic Epidemiology GOLDSTEIN, ALISA NIH $909,165
Hodgkin's Disease 2015 NCI 1ZIACP010131-20 Studies of Populations Exposed to Therapeutic Medical Radiation and Other Agents BERRINGTON, AMY NIH $3,052,779
Hodgkin's Disease 2015 NCI 1ZIASC000550-35 Lymphoma Disease Discovery and Definition JAFFE, ELAINE NIH $835,502
Hodgkin's Disease 2015 NCI 1ZIDBC011658-01 LyMB Clinical Trials Team WALDMANN, THOMAS NIH $1,210,652


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer